Shares sold at $0.5159 to Koski Family, Intrexon, Frederick Telling
By Devika Patel
Knoxville, Tenn., June 30 – Oragenics, Inc. settled a $4.67 million private placement of stock on June 30, according to an 8-K filed Thursday with the Securities and Exchange Commission.
The company sold 9,045,679 common shares at $0.5159 per share. The per-share price represents a 2.66% discount to the June 29 closing share price of $0.53.
Koski Family LP invested $2 million and Intrexon Corp. and chairman Frederick Telling also participated.
Proceeds will be used for research and development and general corporate purposes.
Oragenics is a Tampa, Fla.-based biopharmaceutical company focused on novel antibiotics for infectious disease and probiotics for oral health for humans and pets.
| Issuer: | Oragenics, Inc.
|
| Issue: | Common stock
|
| Amount: | $4,666,666
|
| Shares: | 9,045,679
|
| Price: | $0.5159
|
| Warrants: | No
|
| Investors: | Koski Family LP (for $2 million), Intrexon Corp. and Frederick Telling
|
| Settlement date: | June 30
|
| Stock symbol: | NYSE: OGEN
|
| Stock price: | $0.53 at close June 29
|
| Market capitalization: | $20.43 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
